iPLATO Healthcare is a London based company dedicated to mHealth since 2006.
iPLATO’s mobile health solutions have proven to transform patient services and reduce health inequalities across populations. Responding to international demand for mHealth the company is currently expanding into the United States, India and Europe.
Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network, healthcare organisations use iPLATO solutions to promote smoking cessation, weight loss, childhood immunisation, vascular checks and cancer screening as well as offer mobile services for people with diabetes, hypertension, epilepsy and HIV.
iPLATO Healthcare has a strong track record in working with healthcare professionals, payers, providers, pharmacies and pharmaceutical companies to improve health outcomes and operational performance.
Tobias Alpsten - Managing Director (Co-Founder)
As iPLATO’s Managing Director, Tobias Alpsten is responsible for setting overall strategy and for overseeing business development, sales, innovation and service delivery.
Tobias works in partnership with leading academic institutions such as the National Hospital for Neurology and Neurosurgery and the Imperial College on research in the area of mobile health. Tobias is a frequent speaker at events and conferences. He is also supporting the British government in setting national strategies for technology based innovation in healthcare through the Horizon Scanning initiative.
Tobias started his career at Accenture’s Paris office in 1996. Later based in London, he joined the ‘Internet revolution’ in 1997 specialising in e-procurement strategy and Business Process Outsourcing. Tobias left Accenture to set up a independent mobile technology consultancy in London in 2000.
Tobias holds a Master of Science in Electrical Engineering and Information Technology from KTH (the Royal Institute of Technology) in Stockholm and ENST (Ecole Nationale Supérieure des Télécommunications) in Paris. He is trilingual in English, French and Swedish.
Martin Rowden - Director Finance & Operations (Co-Founder)
Martin is the CFO of iPLATO and co-founder of the business. In additional to the traditional CFO responsibilities Martin manages all operational aspects of the organisation including the development and support of the company’s mHealth technology solutions.
Martin’s background offers a range of entrepreneurial expertise matched with institutional and global experience spanning over 20 years.
With a BEc and as a qualified Chartered Accountant (ACA), Martin spent 10 years with PriceWaterhouseCoopers in both Canada and Australia in the Financial Advisory Services division before moving to the UK in 1997 and following his passion as an entrepreneur.
Since 1997 Martin has been involved (in varying executive and non-executive roles) in no less than 4 successful technology ‘start-ups’. In 2005 he co-founded iPLATO Healthcare with Tobias to focus on the nascent but emerging area of mHealth.
Mike Lewis - Chairman
Mike Lewis joined iPLATO as a non-executive director in February 2013 bringing over 25 years of global Health industry experience to the company.
Having previously been EMEA President of medical device company Gambro with responsibility for $1.3Billion in sales and 1000 direct staff he also was Head of Global Marketing, Strategy and Product Development. Gambro was subsequently sold for $3,9Bn to private equity company EQT/Investor.
He has also held senior roles in operations, general management, strategy, marketing and sales at Align Technology (based in Amsterdam), Boston Scientific (based in Paris) where they grew the business from $400M revenue to $2.2B in 4 years at C.R. Bard (based in New Jersey), Sybron (based in Switzerland) and Becton Dickinson, Merck and Sandoz (based in the UK).
Mike is also currently CEO/Chairman of Ranier Technology a UK based Orthopaedic materials innovator and Chairman of Haemo2, a Biotech developing artificial haemoglobin. He is an industrial advisor for private equity organisations and has worked with Apax Partners, Advent International and Electra Capital and was recently Senior Board member at Antisoma plc. Mike has also worked as Board advisor for Smart Surgical Ltd, the ICENI group and various Universities including Imperial College, London and University of Essex. He also lectures for University of Colorado MBA programme and is a speaker at Oxbridge Biotech.
iPLATO is growing. We are always interested in hearing from ambitious and talented team-workers with a passion for healthcare. If you would like us to consider your qualifications, please send a full CV and cover letter to email@example.com